{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:19:06Z","timestamp":1780316346041,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Umea University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Metabolic dysfunction-associated steatohepatitis (MASH) is a common but frequently unrecognized complication of obesity and type 2 diabetes. The association between these conditions is multifaceted and involves complex interactions between metabolic, inflammatory, and genetic factors. Here we assess the underlying structural and molecular processes focusing on the immunological phase of MASH in the nonobese inflammation and fibrosis (NIF) mouse model and compare it to the human disease as well as other murine models. Histopathology together with synchrotron-radiation-based x-ray micro-computed tomography (SR\u00b5CT) was used to investigate structural changes within the hepatic sinusoids network in the NIF mouse in comparison to patients with different severities of MASH. A time-course, bulk RNA-sequencing analysis of liver tissue from NIF mice was performed to identify the dynamics of key processes associated with the pathogenesis. Transcriptomics profiling of the NIF mouse revealed a gradual transition from an initially reactive inflammatory response to a regenerative, pro-fibrotic inflammatory response suggesting new avenues for treatment strategies that focus on immunological targets. Despite the lack of metabolic stress induced liver phenotype, a large similarity between the NIF mouse and the immunological phase of human MASH was detected. The translational value was further supported by the comparative analyses with MASH patients and additional animal models. Finally, the impact of diets known to induce metabolic stress, was explored in the NIF mouse. An obesogenic diet was found to induce key physiological, metabolic, and histologic changes akin to those observed in human MASH.<\/jats:p>","DOI":"10.1038\/s41598-024-73150-z","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T10:02:11Z","timestamp":1727949731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Structure-function analysis of time-resolved immunological phases in metabolic dysfunction-associated fatty liver disease (MASH) comparing the NIF mouse model to human MASH"],"prefix":"10.1038","volume":"14","author":[{"given":"Anja","family":"Schmidt-Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustaw","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Laprade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnaz","family":"Pirzamanbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"H\u00f6rnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajsa","family":"Linde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Skarsfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana J.","family":"Leeming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajmund","family":"Mokso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Verezhak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedrana","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"\u00d6nnerhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoud Rezaee","family":"Oghazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Mayans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"73150_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","volume":"127","author":"Y Koyama","year":"2017","unstructured":"Koyama, Y. & Brenner, D. A. Liver inflammation and fibrosis. J. Clin. Invest.127, 55\u201364 (2017).","journal-title":"J. Clin. Invest."},{"key":"73150_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol.15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"73150_CR3","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","volume":"29","author":"SA Harrison","year":"2023","unstructured":"Harrison, S. A., Allen, A. M., Dubourg, J., Noureddin, M. & Alkhouri, N. Challenges and opportunities in NASH drug development. Nat. Med.29, 562\u2013573 (2023).","journal-title":"Nat. Med."},{"key":"73150_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the study of liver diseases. Hepatology67, 328\u2013357 (2018).","journal-title":"Hepatology"},{"key":"73150_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","volume":"5","author":"JK Dyson","year":"2014","unstructured":"Dyson, J. K., Anstee, Q. M. & McPherson, S. Non-alcoholic fatty liver disease: A practical approach to diagnosis and staging. Frontline Gastroenterol.5, 211\u2013218 (2014).","journal-title":"Frontline Gastroenterol."},{"key":"73150_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","volume":"15","author":"VW Wong","year":"2018","unstructured":"Wong, V. W., Adams, L. A., de Ledinghen, V., Wong, G. L. & Sookoian, S. Noninvasive biomarkers in NAFLD and NASH - current progress and future promise. Nat. Rev. Gastroenterol. Hepatol.15, 461\u2013478 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"73150_CR7","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.3350\/cmh.2022.0426","volume":"29","author":"TC Yip","year":"2023","unstructured":"Yip, T. C. et al. Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: Present and future. Clin. Mol. Hepatol.29, S171\u2013S183 (2023).","journal-title":"Clin. Mol. Hepatol."},{"key":"73150_CR8","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 65, 1038\u20131048 (2016).","journal-title":"Metabolism"},{"key":"73150_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","volume":"79","author":"F Tacke","year":"2023","unstructured":"Tacke, F., Puengel, T., Loomba, R. & Friedman, S. L. An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH. J. Hepatol.79, 552\u2013566 (2023).","journal-title":"J. Hepatol."},{"key":"73150_CR10","doi-asserted-by":"publisher","first-page":"e0159850","DOI":"10.1371\/journal.pone.0159850","volume":"11","author":"N Fransen-Pettersson","year":"2016","unstructured":"Fransen-Pettersson, N. et al. A new mouse model that spontaneously develops chronic liver inflammation and fibrosis. PLoS One11, e0159850 (2016).","journal-title":"PLoS One"},{"key":"73150_CR11","doi-asserted-by":"publisher","first-page":"21778","DOI":"10.1038\/s41598-020-78688-2","volume":"10","author":"J Nilsson","year":"2020","unstructured":"Nilsson, J. et al. NKT cells promote both type 1 and type 2 inflammatory responses in a mouse model of liver fibrosis. Sci. Rep.10, 21778 (2020).","journal-title":"Sci. Rep."},{"key":"73150_CR12","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/liv.14390","volume":"40","author":"MA Karsdal","year":"2020","unstructured":"Karsdal, M. A. et al. Collagen biology and non-invasive biomarkers of liver fibrosis. Liver Int.40, 736\u2013750 (2020).","journal-title":"Liver Int."},{"key":"73150_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jhep.2022.11.028","volume":"78","author":"DGK Rasmussen","year":"2023","unstructured":"Rasmussen, D. G. K. et al. NAFLD and NASH biomarker qualification in the LITMUS consortium - lessons learned. J. Hepatol.78, 852\u2013865 (2023).","journal-title":"J. Hepatol."},{"key":"73150_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12931-016-0394-8","volume":"17","author":"NU Hansen","year":"2016","unstructured":"Hansen, N. U. et al. Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor. Respir. Res.17, 76 (2016).","journal-title":"Respir. Res."},{"key":"73150_CR15","doi-asserted-by":"publisher","first-page":"12414","DOI":"10.1038\/s41598-018-30457-y","volume":"8","author":"Y Luo","year":"2018","unstructured":"Luo, Y. et al. An evaluation of the collagen fragments related to fibrogenesis and fibrolysis in nonalcoholic steatohepatitis. Sci. Rep.8, 12414 (2018).","journal-title":"Sci. Rep."},{"key":"73150_CR16","doi-asserted-by":"publisher","first-page":"E529","DOI":"10.1152\/ajpendo.00245.2023","volume":"325","author":"SA Melander","year":"2023","unstructured":"Melander, S. A. et al. Dual amylin and calcitonin receptor agonist treatment reduces biomarkers associated with kidney fibrosis in diabetic rats. Am. J. Physiol. Endocrinol. Metab.325, E529\u2013E539 (2023).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"73150_CR17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00535-016-1190-4","volume":"51","author":"T Greuter","year":"2016","unstructured":"Greuter, T. & Shah, V. H. Hepatic sinusoids in liver injury, inflammation, and fibrosis: New pathophysiological insights. J. Gastroenterol.51, 511\u2013519 (2016).","journal-title":"J. Gastroenterol."},{"key":"73150_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","volume":"69","author":"T Tsuchida","year":"2018","unstructured":"Tsuchida, T. et al. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J. Hepatol.69, 385\u2013395 (2018).","journal-title":"J. Hepatol."},{"key":"73150_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12876-020-01356-2","volume":"20","author":"HH Hansen","year":"2020","unstructured":"Hansen, H. H. et al. Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis. BMC Gastroenterol.20, 210 (2020).","journal-title":"BMC Gastroenterol."},{"key":"73150_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nri.2017.90","volume":"18","author":"RL Gieseck","year":"2018","unstructured":"Gieseck, R. L. 3, Wilson, M. S., Wynn, T. A. & rd, Type 2 immunity in tissue repair and fibrosis. Nat. Rev. Immunol.18, 62\u201376 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"73150_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","volume":"13","author":"F Heymann","year":"2016","unstructured":"Heymann, F. & Tacke, F. Immunology in the liver\u2013from homeostasis to disease. Nat. Rev. Gastroenterol. Hepatol.13, 88\u2013110 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"73150_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","volume":"15","author":"S Schuster","year":"2018","unstructured":"Schuster, S., Cabrera, D., Arrese, M. & Feldstein, A. E. Triggering and resolution of inflammation in NASH. Nat. Rev. Gastroenterol. Hepatol.15, 349\u2013364 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"73150_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nri3831","volume":"15","author":"TA Wynn","year":"2015","unstructured":"Wynn, T. A. Type 2 cytokines: Mechanisms and therapeutic strategies. Nat. Rev. Immunol.15, 271\u2013282 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"73150_CR24","doi-asserted-by":"crossref","unstructured":"Hart, K. M. et al. Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-beta. Sci. Transl. Med.9, (2017).","DOI":"10.1126\/scitranslmed.aal3694"},{"key":"73150_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","volume":"16","author":"J Gracia-Sancho","year":"2019","unstructured":"Gracia-Sancho, J., Marrone, G. & Fernandez-Iglesias, A. Hepatic microcirculation and mechanisms of portal hypertension. Nat. Rev. Gastroenterol. Hepatol.16, 221\u2013234 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"73150_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cmet.2018.10.012","volume":"29","author":"MA Febbraio","year":"2019","unstructured":"Febbraio, M. A. et al. Preclinical models for studying NASH-Driven HCC: How useful are they?. Cell. Metab.29, 18\u201326 (2019).","journal-title":"Cell. Metab."},{"key":"73150_CR27","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/jgh.14122","volume":"33","author":"F Haczeyni","year":"2018","unstructured":"Haczeyni, F. et al. Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature. J. Gastroenterol. Hepatol.33, 1312\u20131320 (2018).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"73150_CR28","doi-asserted-by":"publisher","first-page":"e0244763","DOI":"10.1371\/journal.pone.0244763","volume":"16","author":"JK Carter","year":"2021","unstructured":"Carter, J. K. et al. Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales. PLoS One16, e0244763 (2021).","journal-title":"PLoS One"},{"key":"73150_CR29","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"73150_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1365-2818.2002.01010.x","volume":"206","author":"D Paganin","year":"2002","unstructured":"Paganin, D., Mayo, S. C., Gureyev, T. E., Miller, P. R. & Wilkins, S. W. Simultaneous phase and amplitude extraction from a single defocused image of a homogeneous object. J. Microsc.206, 33\u201340 (2002).","journal-title":"J. Microsc."},{"key":"73150_CR31","doi-asserted-by":"crossref","unstructured":"Laprade, W., Perslev, M. & Sporring, J. How Few Annotations are Needed for Segmentation Using a Multi-planar U-Net? In: MICCAI Workshop on Deep Generative Models. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) Springer.; pp. 209\u2013216. (2021).","DOI":"10.1007\/978-3-030-88210-5_20"},{"key":"73150_CR32","unstructured":"Krueger, F. TrimGalore (version 0.6.4). In; (2016)."},{"key":"73150_CR33","unstructured":"Martin, S. Cutadapt (version 2.4). In; (2011)."},{"key":"73150_CR34","unstructured":"Andrews, S. & Andrews, S. FastQC: A quality control tool for high throughput sequence data. In: 2010. (2010)."},{"key":"73150_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"73150_CR36","doi-asserted-by":"crossref","unstructured":"Love, M. I. & Huber, W. S. A. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. ;15. (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"73150_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B (Mtehodol.)57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B (Mtehodol.)"},{"key":"73150_CR38","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. (Camb)2, 100141 (2021).","journal-title":"Innov. (Camb)"},{"key":"73150_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res.28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73150-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73150-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73150-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T10:05:10Z","timestamp":1727949910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73150-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73150"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73150-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3875867\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]},"assertion":[{"value":"18 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DH and SM are shareholders and MH and KL are full time employees of Inficure Bio; DJL and MS are full time employees and shareholders of Nordic Bioscience. ASC, GE, WML, BP, JN, RM, MV, AD, VD, K\u00d6, and MRO do not have any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23014"}}